Percutaneous Coronary Intervention
TWILIGHT: Benefit of ticagrelor monotherapy after PCI similar in men, women
Among patients who underwent PCI with a drug-eluting stent, switching from dual antiplatelet therapy to ticagrelor monotherapy at 3 months was similarly beneficial in men and women, according to new data from the TWILIGHT trial.
Restructuring needed to combat backlog of interventional procedures due to pandemic
Excess CV mortality due to the pandemic has been observed globally, and clinicians may need to consider restructuring services to meet the backlog of patients on the waiting list to undergo lifesaving interventions, a speaker reported.
SCAI to launch new journal in January 2022
The Society for Cardiovascular and Angiography Interventions announced the launch of a new journal, the Journal of the Society for Cardiovascular Angiography and Interventions.
SCAI updates cath lab best practices for delivery of high-quality care
The Society for Cardiovascular Angiography and Interventions has updated its guideline on best practices in the cardiac catheterization laboratory.
STEMI after TAVR tied to risk for poor outcomes
Among patients with STEMI, prior transcatheter aortic valve replacement was associated with high rates of poor in-hospital and midterm clinical outcomes, according to a study published in the Journal of the American College of Cardiology.
ISCHEMIA population underrepresented among those who undergo PCI for stable CAD
In a cohort of real-world patients with stable ischemic heart disease who underwent PCI, only 14% could be classified similarly to patients from the ISCHEMIA trial, researchers reported.
At height of pandemic, patients presenting with acute MI dropped drastically
The number of patients presenting with acute MI significantly declined during the peak of the COVID-19 pandemic, according a presentation at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Robotic PCI confers high rates of technical, clinical success
The second generation of a robotic PCI system was associated with high rates of clinical and technical success, according to a presentation at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions.
In high-risk ACS, long-term DAPT confers reduced ischemic events without rise in bleeding
Among patients at high ischemic and bleeding risk, longer duration of dual antiplatelet therapy after PCI for ACS was associated with lower risk for adverse events at 30 months vs. shorter duration DAPT, a speaker reported.
Mortality high, PCI common in patients with concomitant STEMI, COVID-19: NACMI Registry
In-hospital mortality remains high and primary PCI is common in patients with STEMI and COVID-19, according to new data from the North American COVID-19 Myocardial Infarction Registry.